Cost-effectiveness analysis of MASLD screening using FIB-4 based two-step algorithm in the medical check-up
Abstract Screening for metabolic dysfunction-associated steatotic liver disease (MASLD) across the entire general population is not currently a recommended strategy. However, it is not uncommon to receive a medical check-up or health check-up for a various of reasons. We tried to investigate whether...
Saved in:
| Main Authors: | Mimi Kim, Huiyul Park, Eileen L. Yoon, Ramsey Cheung, Donghee Kim, Hye-Lin Kim, Dae Won Jun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-01740-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests
by: Huiyul Park, et al.
Published: (2025-07-01) -
Non-Invasive Tests as a Replacement for Liver Biopsy in the Assessment of MASLD
by: Julia Frączek, et al.
Published: (2025-04-01) -
Modified FIB-4 Index in Type 2 Diabetes Mellitus with Steatosis: A Non-Linear Predictive Model for Advanced Hepatic Fibrosis
by: Jonghyun Kim, et al.
Published: (2024-11-01) -
Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank
by: Qi Feng, et al.
Published: (2025-07-01) -
Useful Biomarkers for Preeclampsia: Evaluating the Diagnostic Potential of FIB-4 and FIB-5 Indices
by: Mehmet Albayrak, et al.
Published: (2025-03-01)